ProShares Ultra Nasdaq Biotechnology (BIB) Holdings $42.21 -0.34 (-0.80%) Closing price 03:59 PM EasternExtended Trading$42.22 +0.02 (+0.04%) As of 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Top 50 BIB HoldingsRankCompanyCurrent PriceWeightShares Held1United States Treasury Bills 0%N/A14.07%7,500,0002United States Treasury Bills 0%N/A7.51%4,000,0003Cte ? Proshares Trust MN/A7.13%3,777,7444VRTXVertex Pharmaceuticals$498.89+0.6%6.88%7,5405AMGNAmgen$295.09+0.4%6.78%11,7436GILDGilead Sciences$105.35-1.1%6.68%31,6467REGNRegeneron Pharmaceuticals$563.53-1.3%5.73%4,8508United States Treasury Bills 0%N/A5.61%3,000,0009AZNAstraZeneca$67.96-0.1%3.58%26,26910ALNYAlnylam Pharmaceuticals$233.24-2.8%2.94%5,840 Get the Latest News and Ratings for BIB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 11CashN/A1.99%1,053,25412BIIBBiogen$117.90-1.1%1.64%6,60313ARGXargenx$602.85-0.6%1.59%1,44414United States Treasury Bills 0%N/A1.40%750,00015SNYSanofi$51.48-0.7%1.32%12,96316SMMTSummit Therapeutics$23.66-9.4%1.29%33,27817UTHRUnited Therapeutics$283.95-0.1%1.19%2,02618RPRXRoyalty Pharma$32.31+0.1%1.15%19,54819INSMInsmed$69.80-1.7%1.13%8,16520BMRNBioMarin Pharmaceutical$59.97+0.5%1.11%8,60621ILMNIllumina$75.13+0.1%1.10%7,14622INCYIncyte$58.68-0.9%1.03%8,73023ONCBeigene$238.43-1.8%0.98%1,88824NBIXNeurocrine Biosciences$95.24+0.4%0.92%4,49825MRNAModerna$26.08-2.7%0.91%17,40526EXELExelixis$36.19+1.3%0.88%12,62627VTRSViatris$7.53-1.4%0.88%53,84928MEDPMedpace$303.54-0.6%0.81%1,37429BNTXBioNTech$99.81-2.5%0.79%4,48830ASNDAscendis Pharma A/S$153.56-1.2%0.78%2,72431TEMTempus AI$42.13-2.3%0.71%7,54132HALOHalozyme Therapeutics$61.65+0.4%0.66%5,55633JAZZJazz Pharmaceuticals$104.01+2.2%0.65%2,74034MDGLMadrigal Pharmaceuticals$320.11-0.7%0.63%99635ROIVRoivant Sciences$10.05-1.4%0.61%32,18936BBIOBridgeBio Pharma$34.20-1.9%0.56%8,58037RVMDRevolution Medicines$36.01-1.3%0.55%8,38738SRPTSarepta Therapeutics$54.07-1.0%0.52%4,37739BPMCBlueprint Medicines$80.83-2.1%0.49%2,88340AXSMAxsome Therapeutics$101.79-1.7%0.46%2,200Altucher: Turn $900 into $108,000 in just 12 months? (Ad)We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.If I’m right about this (like I was before) a modest $900 investment…41GHGuardant Health$45.54+0.8%0.46%5,56842ALKSAlkermes$27.68+0.5%0.45%7,33643KRYSKrystal Biotech$166.98-1.1%0.44%1,29944ADMAADMA Biologics$21.73+3.9%0.41%10,66445CYTKCytokinetics$38.86-2.4%0.41%5,34246NUVLNuvalent$68.54-2.1%0.40%2,98547VRNAVerona Pharma$58.77+1.7%0.40%3,55548IONSIonis Pharmaceuticals$28.49-0.7%0.39%7,17149PCVXVaxcyte$30.02-6.3%0.37%5,80950PTCTPTC Therapeutics$47.19+4.7%0.32%3,558 Geographic ExposureUnited States107.5%Ireland1.0%Bermuda0.6%Canada0.4%Netherlands0.4%Switzerland0.3%Luxembourg0.2%United Kingdom0.2%Jersey0.2%Singapore0.1%Sector ExposureHealth Care76.0%Consumer Discretionary0.7%Energy0.1%Biotechnology0.1%Industry ExposureBiotechnology69.3%Pharmaceuticals3.2%Health Care Equipment & Supplies1.8%Diversified Consumer Services1.3%Life Sciences Tools & Services1.0%Distributors0.2%Renewable Energy0.1% Related Companies and Tools Related Companies F/m Emerald Life Sciences Innovation ETF Top Holdings Invesco Nasdaq Biotechnology ETF Top Holdings Global X HealthTech ETF Top Holdings Horizon Kinetics Medical ETF Top Holdings First Trust Nasdaq Pharmaceuticals ETF Top Holdings JPMorgan Healthcare Leaders ETF Top Holdings ProShares UltraShort Nasdaq Biotechnology Top Holdings Invesco Dorsey Wright Healthcare Momentum ETF Top Holdings Invesco S&P SmallCap Health Care ETF Top Holdings VanEck Biotech ETF Top Holdings This page (NASDAQ:BIB) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares Ultra Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares Ultra Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.